Join us every lunch from April 10-12 to see our handpicked posters that are demonstrating some of the most cutting edge research.
Serum Antibody response and Dengue virus cross-reactivity profiling after Zika virus infection in rhesus macaques.
John C. Tan1, Emma L. Mohr3, Adam Bailey2, Adam Ericson2, Connor Buechler2, Dawn M. Dudley2, Christina Newman2, Mariel S. Mohns2, Meghan E. Breitbach2, Laurel Stewart2, Sarah J. Barilovits1, Jigar Patel1, David H. O’Connor2
Affiliations: 1Roche Sequencing Solutions, Inc., 2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 3Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison
Serum and Antibody Profiling Applications of Roche Innovation Madison High-Density Peptide Arrays
Brad Garcia1, Ken Lo1, John C. Tan1, Eric Sullivan1, Ryan Bannen1, Klaus-Peter Stengele2, Thomas Albert1, Jigar Patel1
Affiliations: 1Department of Innovation, Roche Sequencing Solutions – Madison, 500 S. Rosa Road, Madison WI 53719, USA; 2Roche Diagnostics, Nonnenwald 2, Penzberg, Germany
Intranasal Delivery of VitriLife® Live-Attenuated Influenza Vaccine Powder Elicits Robust and Protective Immune Responses in Ferrets.
Victor Bronshtein, Ph.D.; S. Mark Tompkins, Ph.D.; Tatiana Bousse, Ph.D.; Min-Xuan Wang, B.Sc.; Erin A. Miller, B.Sc.; Edward Vonsovich, M.D.; Scott K. Johnson, M.S.; Cheryl A. Jones, B.Sc.; Jasmina M. Luczo, Ph.D.; David E. Wentworth, Ph.D.; Nikolai Petrovsky, M.D.; Mark Papania, M.D. MPH
Development of a third generation of Her-2/neu multipeptide vaccine including Trastuzumab and Pertuzumab binding site mimotopes.
Joshua Tobias1, Karin Baier, Katharina Ambroz, Dejana Dejanovic1, Christoph C. Zielinski2, Ursula Wiedermann
Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Immunology & Infectiology, Medical University of Vienna, Vienna, Austria
Division of Oncology, Department of Medicine I, Medical University of Vienna, General Hospital, Vienna, Austria
MDCK Proliferation and Flu Production in Suspension Culture on Various Microcarriers
Media Research & Technology, Lonza Walkersville, Inc,
8830 Biggs Ford Road, Walkersville, MD, 21793, USA
Adding insulin to increase influenza virus yield in HEK293 cells for vaccine production
Aziza P. Manceur, Sonia Tremblay, Sven Ansorge
National Research Council Canada, Human Health Therapeutics Portfolio, Vaccine Program, Montreal, Quebec, Canada
Hemocyanins from mollusk as a potent adyuvants/immunostimulants for vaccines
Alfredo E. De Ioannes 1 and María Inés Becker 1, 2
Biosonda Corporation, Santiago, Chile firstname.lastname@example.org
Fundación Ciencia y Tecnología para el Desarrollo (FUCITED), Santiago, Chile
Novel Synthetic vaccines: Immunogenicity of membrane antigens produced with artificial cell membrane technology
Tom Cornell, Fabien Décaillot, Xingfang Su, Madhavan Nallani
ACM Biolabs Pte Ltd, Innovation Centre Blk 2, 18 Nanyang Drive, Singapore 637723, email@example.com
Optimization and qualification of anti-Salmonella Typhi Vi ELISA to assess immunogenicity of Vi conjugate typhoid vaccin
Mi Seon Jang, Eun Young Lee, Manki Song, Jae Seung Yang
Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformation of the F Glycoprotein